CD4 and breast carcinoma: In certain tumors such as breast cancer, the presence of memory phenotype T cells are a prognostic indicator for anti-tumor responses, with an increase in TCM-like and decrease in TEM-like CD4+ cells in the lymph nodes of patients progressing from stage I to stage III disease (188).